These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9797710)

  • 21. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
    Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
    Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
    Sallinen H; Heikura T; Laidinen S; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
    Int J Gynecol Cancer; 2010 Dec; 20(9):1498-505. PubMed ID: 21119365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 receptor and ovarian cancer.
    Owens OJ; Taggart C; Wilson R; Walker JJ; McKillop JH; Kennedy JH
    Br J Cancer; 1993 Aug; 68(2):364-7. PubMed ID: 8347492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery].
    Zhu X; Ying LS; Xu SH; Zhu CH; Xie JB
    Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):666-70. PubMed ID: 21176531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
    Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
    Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma in beta(o)-thalassemia/HbE and their clinical significance.
    Wanachiwanawin W; Wiener E; Siripanyaphinyo U; Chinprasertsuk S; Mawas F; Fucharoen S; Wickramasinghe SN; Pootrakul P; Visudhiphan S
    J Interferon Cytokine Res; 1999 Feb; 19(2):105-11. PubMed ID: 10090395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
    Plante M; Rubin SC; Wong GY; Federici MG; Finstad CL; Gastl GA
    Cancer; 1994 Apr; 73(7):1882-8. PubMed ID: 8137215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased interleukin-32, interleukin-1, and interferon-γ levels in serum from hepatitis B patients and in HBV-stimulated peripheral blood mononuclear cells from healthy volunteers.
    Tian ZJ; Shen Y; Li XR; Wei YN; Fan H; Ren QK
    J Infect Public Health; 2019; 12(1):7-12. PubMed ID: 30006119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer.
    Brakora KA; Lee H; Yusuf R; Sullivan L; Harris A; Colella T; Seiden MV
    Gynecol Oncol; 2004 May; 93(2):361-5. PubMed ID: 15099946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor.
    Orengo AM; Fabbi M; Miglietta L; Andreani C; Bruzzone M; Puppo A; Cristoforoni P; Centurioni MG; Gualco M; Salvi S; Boccardo S; Truini M; Piazza T; Canevari S; Mezzanzanica D; Ferrini S
    Int J Cancer; 2011 Sep; 129(5):1116-25. PubMed ID: 21710494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
    Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
    Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: Attenuated the production of inflammatory cytokines.
    Xia L; Shen H; Lu J
    Cytokine; 2015 Dec; 76(2):553-557. PubMed ID: 26159110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma.
    Malekzadeh M; Dehaghani AS; Ghaderi A; Doroudchi M
    Cancer Biomark; 2013 Jan; 13(6):417-25. PubMed ID: 24595078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms.
    Kutteh WH; Kutteh CC
    Am J Obstet Gynecol; 1992 Dec; 167(6):1864-9. PubMed ID: 1471711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
    Liou LB
    Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.